CSG’s Strategic Push Into US Defense Collides With a Sector-Wide Rout
25.06.2026 - 17:13:06 | boerse-global.de
Europe’s defense sector is caught in a punishing downdraft, and the Czechoslovak Group (CSG) is taking the brunt. The Prague-based munitions and military equipment maker has seen its shares collapse more than 64% from the January record high of €36.05, closing recently at €12.92 — barely a whisker above the 52-week trough of €12.31. Over the past 30 days alone, the stock has shed nearly 32% of its value.
Yet beneath the surface of this brutal selloff, CSG is quietly executing one of its most ambitious strategic gambits: a full-bore assault on the American defense market.
The company has tapped David Jacobs, a veteran of Northrop Grumman and Raytheon with more than 15 years in the industry, to lead CSG Defense North America. Jacobs, who most recently served as a vice president at Northrop advising on acquisitions and spent a decade in investment banking at Merrill Lynch handling deals worth over $200 billion, will build a new Washington office. He reports directly to majority owner Michal Strnad and holds a broad mandate to steer US strategy and engineer takeovers in North America.
The push is not just about lobbying. CSG already secured a US Army contract last year for an artillery shell factory in Iowa through its subsidiary MSM Group — a facility slated to produce 155-millimeter rounds. Jacobs is now tasked with expanding production capacity, forging partnerships, and facilitating direct technology transfer.
Should investors sell immediately? Or is it worth buying CSG?
That expansion narrative, however, has been completely overwhelmed by a sector-wide mood swing that is punishing European defense stocks indiscriminately. The trigger is a paradox: speculation about a potential end to the conflicts in Ukraine and the Middle East, combined with Germany’s decision to cancel an order for six F126 frigates. Rheinmetall suffered its biggest single-day loss ever on that news, while Hensoldt, Renk, Saab, Leonardo, and BAE Systems all slid on the same session — even as the broad STOXX Europe 600 barely budged.
The market is effectively questioning whether the promised increases in NATO defense budgets will ever translate into actual orders, margins, and cash flows at the pace previously assumed. For CSG, that skepticism has become acute.
The divergence between sentiment and fundamentals is stark. In the first quarter of 2026, CSG posted revenue of €1.544 billion, up 13.8% year-on-year. The order backlog swelled 15.1% to €17 billion. Operating EBIT came in at €372 million. The ammunition business grew 26.5% in the quarter, with medium- and large-caliber rounds in heavy demand. Management confirmed its full-year and medium-term guidance. Production of large-caliber rounds is on track to hit 850,000 units by end-2026, up from 550,000 last year, with an additional 400,000 rounds from reactivated lines.
Geographically, the company is more diversified than headlines suggest. Europe excluding Ukraine accounts for 49% of sales, Ukraine itself 21%, and the United States 16%. The Ukraine share is actually declining in relative terms as other markets — notably Southeast Asia — gain weight.
None of that has arrested the stock’s slide. Technically, CSG is deeply oversold: it trades 26% below its 50-day moving average of €16.88 and more than 40% below the 100-day average. The 14-day relative strength index stands at 25.9, well under the 30 threshold typically considered oversold. The annualized 30-day volatility has hit nearly 59%.
CSG at a turning point? This analysis reveals what investors need to know now.
Investors are demanding concrete results rather than strategic visions. The appointment of David Jacobs and the new Washington office provide the institutional access, but the market wants to see signed contracts or completed acquisitions before it turns. “Only when the US push delivers measurable order intake or closed deals should the downward pressure ease,” the secondary article notes.
The next major test arrives on August 7, 2026, when CSG releases its half-year results for the first six months of the year. By then, either the sector-wide rout will have dissipated, or markets will have begun reassessing CSG’s backlog conversion, ammunition franchise, and overall growth narrative. For now, the gap between a company building a Washington beachhead and a stock trading near its 52-week low has rarely been wider.
Ad
CSG Stock: New Analysis - 25 June
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
